|

|
COMPLIMENTARY registration for
IN3 Summit & Investor Day
attendees
[click
here] |
Reimbursement,
Valuation, Investor
Presentations, and
Regulatory Strategy:
This webinar
covers each of these
critical elements in
life science company
development,
illustrating how
making the right
decisions early can
ensure funding and
avoid costly,
time-consuming and
some-times
disastrous errors.
Here’s some of what
you’ll learn during
this 90-minute
webinar:
-
Where 168
lifescience VCs
invest and how
this information
will allow you
to target those
who will say
“yes”.
-
How to bracket
your projections
to develop a
realistic story,
even if you may
not know the
real numbers.
-
How paying
attention to
regulatory
timeframes to
secure new
reimbursement
can pay off in
early product
adoption.
-
How developing a
pricing strategy
that connects to
the clinical or
economic value
of the
technology can
reap dividends
on company
valuation and
commercialization.
-
How asking tough
questions of
your target
market
positively
affects your
funding
potential.
-
10 must-include
slides in your
financial
presentation to
capture the
confidence of
investors.
-
A sure-fire
method of
presenting your
prior, current,
and future burn
that will answer
investors'
critical
questions.
-
How timeline to
exit should be
presented to set
realistic
expectations.
-
How having no
competition can
create an alarm
in the
investment
community.
-
How using a
technology
superiority
hypothesis in
your pivotal
trial can
enhance your
reimbursement
prospects.
-
How
investigating
the potential
reimbursement
landscape early
in product
development can
favorably impact
product design,
investor
acceptance and
commercialization.
-
How PMA
approvals have
become the
preferred
regulatory
pathway for
reimbursement
decision-makers.
-
What gets lost
in the
commercialization
process when
it’s assumed
that
reimbursement
comes
automatically
upon FDA
clearance.
-
How recognizing
that physicians,
hospitals and
insurers DON’T
share the same
financial
motivations
should influence
every aspect of
product
development,
from product
design to
valuation to
commercialization.
For one low price,
you and your entire
team from one
location can take
part in this
fast-paced,
insightful webinar.
Best of all, you’ll
be able to connect
personally with our
panelists when we
open up the phone
lines for live Q&A.
The discussion will
be delivered in a
convenient audio
conference format,
and capped off with
an interactive Q&A
round.
So join us, in the
convenience of your
own office, for a
thought-provoking
analysis. Grab your
team (or several
teams), a conference
room at your office,
a phone and a
computer with Web
access (that last
one's optional). No
travel required.
|
|
Date:
|
Friday, December
11 |
|
Time: |
2:00 p.m. EDT
1:00 p.m. CDT
11:00 a.m. PDT |
|
Duration:
|
90 minutes |
|
What do I Get?
-
One (1) phone line
for you or your
team.
-
Toll-free in
the U.S.
-
One (1) website
password to see
the presenters'
slides as they
present.
-
Interactive
Q&A with presenters by
phone and e-Questions.
-
Online access
to audio and
slides if can't attend
live.
|
|
|
|
Presented live
by 2 industry experts in lifesciences.
|
|
|
|
NANCY PATTERSON
President
& Founder
Strategy Inc.
www.strategyinc.net
A
lifescience due
diligence and valuation
company. |
 |
|
|
|
|
NANCY REAVEN
President & Founder
Strategic Health
Resources
www.strathealth.com
A
consulting and
data-mining firm founded
in 1996. |
 |
|
|

Register for live webinar: $399
Register for live webinar +
purchase audio
recording: $499
Purchase audio recording only:
$499
Register by email:
custcare@elsevier.com
Register by phone: 1 (800) 332-2181 (U.S.) /
+1 (908) 547-2159 (non- U.S.)
Presented by:

|
©2009 Elsevier Business
Intelligence
The
Elsevier Webcast Series is
produced by IN3 and Windhover
Webinars.
For more information, please
go here.
Windhover Webinars / Elsevier
Business Intelligence
P.O. Box 7247 - Philadelphia, PA
19101-9257
* Tel: +1 (800) 332-2181 (U.S.)
or +1 (908) 547-2159 (non-U.S.)
* Fax: +1 (908) 547-2165 |
|